XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Goodwill and Intangible Assets
 3 Months Ended
Apr. 01, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets GOODWILL AND INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments that carry goodwill, Specialty Chemicals and Engineered Materials (“SCEM”),Advanced Planarization Solutions (“APS”), Microcontamination Control (“MC”), and Advanced Materials Handling (“AMH”), and was as follows:
(In thousands)SCEMAPSMCAMHTotal
December 31, 2022$561,328 $3,530,813 $242,088 $74,102 $4,408,331 
Goodwill impairment— (88,872)— — (88,872)
Disposition of business(89,271)— — — (89,271)
Purchase accounting adjustments10,435 (16,458)— — (6,023)
Assets held-for-sale(1,390)— — — (1,390)
Foreign currency translation(3)24,107 625 — 24,729 
April 1, 2023$481,099 $3,449,590 $242,713 $74,102 $4,247,504 
Our goodwill balances reflect the goodwill impairment of our EC reporting unit of $88.9 million, see Note 3. In addition, the Company sold its QED business and the related goodwill of the business of $89.3 million was included in the disposition, see Note 5.
Identifiable intangible assets at April 1, 2023 and December 31, 2022 consist of the following:
April 1, 2023
(In thousands)Gross carrying
amount		Accumulated
amortization		Net carrying
value
Developed technology$1,300,557 $351,751 $948,806 
Trademarks and trade names244,090 33,404 210,686 
Customer relationships832,016 286,038 545,978 
In-process research and development (1)
31,400 — 31,400 
Other25,787 20,321 5,466 
$2,433,850 $691,514 $1,742,336 
December 31, 2022
(In thousands)Gross carrying
amount		Accumulated
amortization		Net carrying
value
Developed technology$1,302,101 $313,876 $988,225 
Trademarks and trade names250,473 29,565 220,908 
Customer relationships863,947 273,039 590,908 
In-process research and development (1)
31,100 — 31,100 
Other31,206 20,392 10,814 
$2,478,827 $636,872 $1,841,955 
(1) Intangible assets acquired in a business combination that are in-process and used in research and development activities are considered indefinite-lived until the completion or abandonment of the research and development efforts. Once the research and development efforts are completed, we determine the useful life and begin amortizing the assets.
Future amortization expense relating to intangible assets currently recorded in the Company’s condensed consolidated balance sheets is estimated to be the following at April 1, 2023:
(In thousands)Remaining 20232024202520262027ThereafterTotal
Future amortization expense$168,531 210,501 203,951 201,015 197,507 760,831 $1,742,336